Goldman Sachs
OPTN

Goldman Sachs’s OptiNose OPTN Stock Holding History

Goldman Sachs’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,535
Closed -$320K – 6005
2024
Q2 		$320K Buy
20,535
+12,199
+146% +$204K ﹤0.01% 5072
2024
Q1 		$183K Buy
8,336
+2,264
+37% +$50.3K ﹤0.01% 5137
2023
Q4 		$117K Sell
6,072
-1,204
-17% -$22K ﹤0.01% 5270
2023
Q3 		$134K Buy
7,276
+3,244
+80% +$58.4K ﹤0.01% 5130
2023
Q2 		$74.4K Sell
4,032
-667
-14% -$15.8K ﹤0.01% 5405
2023
Q1 		$136K Buy
4,699
+2,720
+137% +$72.4K ﹤0.01% 5409
2022
Q4 		$54.9K Buy
1,979
+334
+20% +$12.7K ﹤0.01% 5583
2022
Q3 		$90K Sell
1,645
-219
-12% -$12K ﹤0.01% 5711
2022
Q2 		$102K Sell
1,864
-4,235
-69% -$156K ﹤0.01% 5859
2022
Q1 		$226K Buy
6,099
+2,411
+65% +$86.1K ﹤0.01% 5817
2021
Q4 		$90K Buy
3,688
+1,676
+83% +$56.1K ﹤0.01% 6163
2021
Q3 		$91K Sell
2,012
-1,057
-34% -$44.3K ﹤0.01% 5933
2021
Q2 		$143K Sell
3,069
-1,996
-39% -$102K ﹤0.01% 5858
2021
Q1 		$281K Sell
5,065
-2,334
-32% -$142K ﹤0.01% 5460
2020
Q4 		$459K Sell
7,399
-2,227
-23% -$136K ﹤0.01% 4658
2020
Q3 		$563K Buy
9,626
+3,750
+64% +$278K ﹤0.01% 4423
2020
Q2 		$656K Buy
5,876
+56
+1% +$3.99K ﹤0.01% 4226
2020
Q1 		$392K Buy
5,820
+3,544
+156% +$357K ﹤0.01% 4354
2019
Q4 		$315K Sell
2,276
-771
-25% -$100K ﹤0.01% 4721
2019
Q3 		$320K Buy
3,047
+1,863
+157% +$186K ﹤0.01% 4658
2019
Q2 		$126K Sell
1,184
-391
-25% -$51.5K ﹤0.01% 4887
2019
Q1 		$243K Sell
1,575
-361
-19% -$41.9K ﹤0.01% 4720
2018
Q4 		$180K Buy
+1,936
New +$276K ﹤0.01% 4860
2018
Q1 		– Sell
-1,739
Closed -$493K – 6250
2017
Q4 		$493K Buy
+1,739
New +$489K ﹤0.01% 4841

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs's OPTN Position: Q3 2024 in Review

Goldman Sachs sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 20,535 shares — an estimated $320K sold.

Goldman Sachs first reported a position in OPTN in Q4 2017 and held it in 24 quarters. The position peaked at $656K in Q2 2020. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Goldman Sachs reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 20,535 OptiNose shares in Q3 2024, an estimated $320K.
  • Goldman Sachs first reported a position in OptiNose in Q4 2017 and held it in 24 quarters.
  • Goldman Sachs's OptiNose position peaked at $656K in Q2 2020.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.